Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 182, Issue -, Pages 1268-1277Publisher
ELSEVIER
DOI: 10.1016/j.ijbiomac.2021.05.058
Keywords
silk scaffold; foreign body reaction; soft tissue engineering
Funding
- Fundamental Research Fund for the Central Universities
- Defense Industrial Technology Development Program [JCKY2017205B032]
- BeijingMunicipal Health Commission [BMC2018-4, BMC2019-9]
Ask authors/readers for more resources
The appropriate dosage of crosslinking agent EGDE is critical for achieving balanced mechanical properties, in vivo degradability, and immunological properties of silk fibroin scaffold platform for soft tissue engineering.
Biologically active scaffolds with tunable mechano-and bio-performance remain desirable for soft tissue engineering. Previously, highly elastic and robust silk fibroin (SF) scaffolds were prepared via cryogelation. In order to get more insight into the role of ethylene glycol diglycidyl ether (EGDE) on the structure and properties of SF scaffolds, we investigated the fate of SF scaffolds with different usages of the crosslinking agent in vitro and in vivo. Although SF scaffolds with varied EGDE contents showed similar micro-morphology, increasing EGDE from 1 mmol/g to 5 mmol/g resulted in firstly increased and later decreased content of beta-sheet conformation, and linearly increased tensile modulus and decreased elasticity. The dual-crosslinked SF scaffolds with EGDE up to 5 mmol/g did not show in vitro cytotoxicity for NIH3T3 fibroblasts. In vivo subcutaneous implantation of SF scaffolds with <3 mmol/g EGDE displayed excellent degradation behavior and tissue ingrowth after 28 days of implantation. However, with >= 3 mmol/g EGDE, SF scaffolds exhibited obvious post-implantation foreign body reactions, probably associated with slow degradation due to excess chemical crosslinks and less mechanical compatibility. These results suggest that an appropriate dosage of crosslinking agent was critical to achieve balanced mechanical properties, degradability in vivo and immuno-properties of the SF scaffold platform for soft tissue engineering. (c) 2021 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available